Lakefront Biotherapeutics repurchases 83,530 shares under buyback program

Corporate Action
โดย Yahoo Finance·Read original
Summary · why it matters

Lakefront Biotherapeutics repurchased 83,530 of its own shares between 22 June and 26 June 2026 as part of the repurchase program announced on 9 June 2026. The shares were bought on Euronext Amsterdam at an average price of €25.24, for a total consideration of €2,108,045.52. Following these transactions, the company holds 199,734 of its own ordinary shares.

Impact on stocks 1

Biotech & Genomic Medicine▲ · 1 stocks
© 2026 MarketDXNews